Editas Medicine EDIT
NASDAQ EDIT
$2.61 +0.04 (+1.36%)
As of: Oct 1, 2026 · 9:41 AM EDT

Editas Medicine (EDIT) Interest Coverage Ratio (2025)

Updated

Editas Medicine's (EDIT) Interest Coverage Ratio was -10.23 for Q3 2025.

Analysis

Editas Medicine (EDIT) Interest Coverage Ratio (2025) Analysis & Trends

Over the twelve months ended Sep 30, 2025, Editas Medicine's Interest Coverage Ratio came in at -29.97.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Editas Medicine 239.69 Mn -472.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -10.23
Jun 30, 2025 -25.52
Mar 31, 2025 -34.37
API Access

Editas Medicine Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=EDIT&period=max&api_key=YOUR_API_KEY